Exchange: NASDAQ·Updated 05:43 AM EDT
COGT logo

COGT Cogent Biosciences Inc

$31.95
$0.452
(1.44%)
Pre-Market
Prev Close $31.50
EarningsNov 3
Mkt Cap$5.47B
Vol169.00

About COGT

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation and other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.
48

Neutral Sentiment

How do you feel about COGT?

Advertisement|Remove ads.